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Summary Malaria infection reduces the binding capacity of benzodiazepine receptors in mice.
We studied the efﬁcacy of diazepam terminating seizures in children with falciparum malaria.
Diazepam stopped seizures in fewer patients with malaria parasitaemia (2 = 3.93, P = 0.047)
and those with clinical diagnosis of malaria (2 = 9.84, P = 0.002) compared to those without.
However malaria was not identiﬁed as an independent risk factor for diazepam’s failure to stopDiazepam;
Malaria; seizures in children.
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Introduction
Acute seizures are common in many children presenting to
sub-Saharan African health facilities (Idro et al., 2008; Ogutu
t al., 2002). In these facilities, diazepam is used as the
andard antiepileptic drug (AED) to stop acute seizures and
atus epilepticus in children, due to its rapid action, low
xpense and wide availability (Mpimbaza et al., 2008; Ogutu
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t al., 2002). Falciparummalaria is a common cause of acute
eizures in children admitted to hospital (Waruiru et al.,
996) and its metabolic and circulatory complications may
ffect the action of drugs. About a third of patients with
alaria and seizures have cerebral malaria (Asindi et al.,
993).
While falciparum malaria does not appear to alter the
harmacokinetics of diazepam (Ogutu et al., 2002), Plas-
odium berghei infection in mice signiﬁcantly decreases
he binding capacity of Gamma-aminobutyric acid-A (GABA-
Open access under CC BY license.) receptors to which benzodiazepines bind (Kokwaro et
l., 1997). Similar studies on effect of malaria on benzo-
iazepine receptors have not been reported in humans.
We assessed the efﬁcacy of intravenous diazepam which
s the preferred route of diazepam administration (Ogutu et
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(16
l., 2002), in treatment of acute seizures in children with
alciparum malaria.
ethods
tudy population
he notes of children presenting to the pediatric ward of Kiliﬁ Dis-
rict Hospital, Kenya with acute convulsions between 1st March
000 and 28th February 2007 were retrospectively evaluated. During
his period the clinical and laboratory features were recorded sys-
ematically on standard proformas. These children were from Kiliﬁ
istrict—–a malaria endemic area where individuals are exposed to
range of <1—120 infectious bites per year (Mbogo et al., 2003).
owever the clinical presentation of malaria is dependent on fac-
ors such as age level of transmission and immunity of the patient
Mwangi et al., 2005; Reyburn et al., 2005).
Malaria was considered to be the primary diagnosis if the child
ad fever and peripheral parasitaemia, without any other cause
f the fever found. Information retrieved on the children with
onvulsions included; age, sex, weight, AED, dose, time of AED
dministration, number and type of seizures, time the seizures
tarted and stopped, history of seizures, clinical diagnosis, con-
cious level for patients with cerebral malaria as deﬁned by a
lantyre Coma Scale of ≤2 (Molyneux et al., 1989), oxygen satura-
ion and falciparum malaria parasitaemia (detected in blood slides
tained with 10% Giemsa).
All children who were given AEDs for acute convulsions were
dentiﬁed. Children with inadequate/missing information or who
ad not been given any AED (seizures lasted <5min and aborted
pontaneously) were excluded.
Either intravenous (IV) diazepam (0.3mg/kg) or intramuscu-
ar (IM) paraldehyde (0.4ml/kg) was used as ﬁrst line treatment,
sually dependent upon the availability of venous access. In the
vent of refractory seizures, a repeat dose of either drug could be
iven. If the seizure did not stop, then second line IV phenobarbital
15mg/kg) or IV phenytoin (18mg/kg) and eventually the third line
thiopental; 4mg/kg) were given, according to the hospital protocol
Ogutu et al., 2002) based on ILAE guidelines (1993).
Diazepam was considered to be effective if it stopped the con-
ulsion in less than 15min with no recurrence (Qureshi et al., 2002).
he point in the treatment protocol at which the seizure was termi-
ated as well as factors such as respiratory depression (deﬁned as
ow oxygen saturation <92% following drug administration) and the
ffect of malaria as the clinical diagnosis, on the efﬁcacy of AEDs
ere evaluated.
tatistical analysis
he data were entered and tabulated in Microsoft Visual Fox-Pro
.0 (Microsoft Corporation) and analysed with Stata (version 9; Stata
orp, College Station, TX, USA). Measures of association were done
sing Pearson’s Chi-square test. We performed a univariate analy-
is of the various risk factors (history of seizures, seizure duration
nd malaria as an underlying condition) and stratiﬁed for possi-
t
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Table 1 Treatment outcome of children given diazepam to stop
Number given d
Patients without P. falciparum parasitaemia 53
Patients with P. falciparum parasitaemia 147
Patients with P. falciparum parasitaemia
and clinical diagnosis of malaria
109M.L. Ikumi et al.
le confounders such as age and sex. A multiple logistic regression
as performed adjusting for history of seizures, age, sex, seizure
uration and malaria as an underlying condition.
esults
total of 1653 children aged 0—12.9 years, admitted during
he 7-year period were given AED to stop acute seizures, of
hom 1189 (72%) had adequate information recorded in the
otes and proforma. Malaria was the most common under-
ying condition, occurring in 566 (48%) of children of whom
39 (42%) had cerebral malaria.
First line AEDs stopped seizures in 298 (25%) of all
atients. Diazepam terminated seizures in fewer patients
ith P. falciparum parasitaemia compared to those with-
ut parasitemia (2 = 3.93, P = 0.047) (Table 1). Diazepam
lso stopped seizures in less children with a primary diag-
osis of malaria compared to those without malaria (40%
s. 62%, 2 = 9.84, P = 0.002). However the level of para-
itaemia did not inﬂuence the outcome and malaria was
ot an independent risk factor for the lack of termina-
ion of seizures (Table 2). Furthermore diazepam was not
igniﬁcantly associated with more episodes of respiratory
epression in children with malaria compared to those with-
ut malaria (3.7% vs 1.1%, Fishers Exact Test = 0.189).
iscussion
his study showed that diazepam is less efﬁcacious in stop-
ing seizures in children with falciaprum malaria. However,
fter adjusting for risk factors, the effect of malaria was
ot statistically signiﬁcant (Table 2). In a study conducted
n Uganda by Mpimbaza et al. (2008) the authors have shown
hat rectal diazepam is less effective in terminating convul-
ions in children with malaria. This result is in agreement
ith previous ﬁndings in Kenyan children which indicated
hat rectal absorption of parenteral diazepam is erratic
nd terminates less seizures than intravenous administra-
ion (Ogutu et al., 2002). Intramuscular paraldehyde does
ot act on benzodiazepine receptors; it is however used as
n alternative ﬁrst line drug to IV diazepam.
Patients with cerebral malaria have reduced plasma and
SF concentrations of histidine an amino acid which is an
mportant constituent of the GABA-A receptor (Mturi et al.,
003), and this may inﬂuence benzodiazepine ligand binding
Wieland et al., 1992). This could be a plausible explana-
ion to diazepam’s decreased binding afﬁnity at the GABA-A
eceptors (Kokwaro et al., 1997) or its reduced clinical efﬁ-
acy in patients with parasitaemia.
The effect of diazepam on respiration also depends upon
he integrity of the benzodiazepine receptors (Braestrup et
acute seizures
iazepam, N = 200 Number (%) in whom seizures stopped
32 (60%)
69 (47%)
44 (40%)
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Table 2 Multiple logistic regression analysis of factors associated with termination of seizures
Seizures stopped, N = 298 Adjusted odds ratio 95% Conﬁdence interval (CI) P-value
Drug: (termination of seizures) 0.32 0.18—0.56 <0.001*
Diazepam vs. 103
Paraldehyde 195
Sex: female 139 1.53 0.90—2.61 0.129
History of seizures 1.10 0.57—2.10 0.767
Yes 199
No 67
Missing 32
Length of seizure after drug administration
<5mina
5—15min 142 0.82 0.40—1.67 0.586
>15min 39 0.13 0.06—0.29 <0.001*
Age
0—6 monthsa
6—12 months 44 0.57 0.20—1.65 0.308
1—3 years 52 0.54 0.18—1.62 0.275
3—6 years 136 0.64 0.24—1.69 0.370
6—13 years 26 2.41 0.51—11.3 0.262
Malaria: Yes 126 0.79 0.44—1.42 0.447
A
B
I
K
M
M
M
Ma This refers to the baseline group in the different categories.
* Represents a signiﬁcant P-value.
al., 1982). The incidence of respiratory depression in this
study is lower than that previously reported (Norris et al.,
1999; Prensky et al., 1967) and may reﬂect the decreased
receptor sensitivity in malaria patients. However there were
insufﬁcient numbers to determine if this occurred signiﬁ-
cantly less frequently in children with malaria.
The difference in diazepam efﬁcacy is not only seen
in the comparison between the malaria group versus the
non-malaria group but those patients with and without par-
asitaemia as a whole. Thus diazepam may be less efﬁcacious
in controlling seizures in children with malaria. However a
randomized trial is needed to clarify these ﬁndings and to
elucidate the effect of malaria on benzodiazepine receptors
in humans.
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